Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (AZD5863)

Recruiting
  • Gastric Cancer
  • +3 more
  • Jacksonville, Florida
  • +16 more
Aug 17, 2023

Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

Completed
  • Gastric Cancer
  • Arm I : Experimental (Prucalopride succinate group)
  • Arm II : Control (Mosapride citrate group)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jul 21, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Bemarituzumab, CAPOX, SOX)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Northport, New York
  • +13 more
Jan 4, 2023

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
Has Results
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Gastric Cancer, Pancreatic Cancer Trial in Seoul (Exercise Therapy, High Protein supplement)

Recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • Exercise Therapy, High Protein supplement
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Oct 7, 2022

Articulated Laparoscopic Instruments Clinical Study

Recruiting
  • Gastric Cancer
  • Minimally Invasive Surgery
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Sep 29, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Duarte, California
  • +170 more
Aug 18, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Gastric Cancer Trial in China, Korea, Republic of, United States (IDX-1197+XELOX, IDX-1197+Irinotecan)

Recruiting
  • Gastric Cancer
  • Los Angeles, California
  • +11 more
Aug 7, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Single Patient Classifier Prediction for Stage II and III

Recruiting
  • Gastric Cancer
    • Seoul, Korea, Republic of
      Novomics. Co., Ltd.
    Jul 21, 2022

    Gastric Cancer Trial in Seoul (Apatinib mesylate)

    Completed
    • Gastric Cancer
    • Apatinib mesylate
    • Seoul, Songpa-gu, Korea, Republic of
      Asan medical center
    Jul 20, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Gastric Cancer Trial in Seoul (Antiviral treatment in combination with low-dose gemcitabine)

    Not yet recruiting
    • Gastric Cancer
    • Antiviral treatment in combination with low-dose gemcitabine
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 21, 2022

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • Gyeonggi-do, Korea, Republic of
    • +4 more
    Jun 14, 2022